Autolus Therapeutics plc (AUTL)
USD 2.29
(-8.03%)
USD 2.29
(-8.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -145.58 Million | -112.3 Million | -117.86 Million | -117.75 Million | -101.48 Million | -25.84 Million |
| Net Income | -208.38 Million | -148.83 Million | -142.09 Million | -142.09 Million | -123.84 Million | -31.11 Million |
| Depreciation & Amortization | 6.56 Million | 7.42 Million | 8.45 Million | 5.65 Million | 4.61 Million | 1.1 Million |
| Deferred income taxes | -986 Thousand | -268 Thousand | -72 Thousand | -1.34 Million | -399 Thousand | -5.21 Million |
| Stock-based compensation | 11.2 Million | 12.01 Million | 9.93 Million | 20.1 Million | 30.21 Million | 5.02 Million |
| Change in working capital | 292 Thousand | 3.96 Million | 4.13 Million | 1.41 Million | -16.2 Million | 5.42 Million |
| Other non-cash items | 45.72 Million | 13.39 Million | 1.77 Million | -1.49 Million | 4.14 Million | -1.07 Million |
| Investing Cash Flow | -10.98 Million | -10.84 Million | -8.85 Million | -14.68 Million | -18.66 Million | -7.64 Million |
| Investments in PPE | -10.98 Million | -10.84 Million | -8.85 Million | -14.68 Million | -18.66 Million | -8.77 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.98 Million | - | - | - | -327 Thousand | 1.12 Million |
| Financing Cash Flow | -883 Thousand | 223.61 Million | 284.06 Million | 74.41 Million | 108.86 Million | 117.48 Million |
| Debt repayment | - | -70 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -3.17 Million |
| Common Stock Issuance | -883 Thousand | 153.61 Million | 245.9 Million | 74.41 Million | 108.86 Million | 128.7 Million |
| Other Financing Activities | -883 Thousand | 223.61 Million | 38.16 Million | -5.79 Million | 108.86 Million | -11.21 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -509 Thousand | 22 Thousand | -1.81 Million | 1.43 Million | -1.45 Million | 8.65 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 801 Thousand | 3.94 Million | 5.95 Million | -29 Thousand | -14.75 Million | -3.23 Million |
| Cash at beginning of period | 382.76 Million | 310.67 Million | 154.08 Million | 211.43 Million | 217.55 Million | 102.31 Million |
| Cash at end of period | 239.56 Million | 382.76 Million | 310.67 Million | 154.08 Million | 211.43 Million | 189.29 Million |
| Capital Expenditure | -10.98 Million | -10.84 Million | -8.85 Million | -14.68 Million | -18.66 Million | -8.77 Million |
| Effect of forex changes on cash | 15.03 Million | -28.37 Million | -754 Thousand | 679 Thousand | 5.16 Million | 2.98 Million |
| Net cash flow / Change in cash | -143.19 Million | 72.08 Million | 156.59 Million | -57.34 Million | -6.12 Million | 86.97 Million |
| Free Cash Flow | -156.57 Million | -123.14 Million | -126.71 Million | -132.43 Million | -120.15 Million | -34.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -58.27 Million | -52.69 Million | -77.17 Million | -208.38 Million | -45.84 Million | -45.55 Million |
| Depreciation & Amortization | 1.89 Million | 1.8 Million | 1.77 Million | 6.56 Million | 1.37 Million | 1.51 Million |
| Deferred income taxes | 74 Thousand | -232 Thousand | -466 Thousand | -986 Thousand | -238 Thousand | -87 Thousand |
| Stock-based compensation | 2.93 Million | 2.28 Million | 3.27 Million | 11.2 Million | 2.86 Million | 2.66 Million |
| Change in working capital | -8.91 Million | -13.75 Million | 20.83 Million | 292 Thousand | -9.65 Million | 1.63 Million |
| Other non-cash items | 18.26 Million | 26.64 Million | 26.92 Million | 45.72 Million | 11.31 Million | 1.68 Million |
| Investing Cash Flow | -841 Thousand | -532.99 Thousand | -1.47 Million | -10.98 Million | -1.49 Million | -4.38 Million |
| Investments in PPE | -841 Thousand | -532.99 Thousand | -1.47 Million | -10.98 Million | -1.49 Million | -4.38 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -10.98 Million | -10.98 Million | - | - |
| Financing Cash Flow | -2.07 Million | 561.44 Million | 23 Thousand | -883 Thousand | 4000.00 | -219 Thousand |
| Debt repayment | -363.99 Thousand | -38.69 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -1.71 Million | 522.74 Million | 23 Thousand | -883 Thousand | 4000.00 | -218.99 Thousand |
| Other Financing Activities | -2.2 Million | 11.17 Million | 23 Thousand | -883 Thousand | 4000.00 | -219 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -334.99 Thousand | 1.31 Million | -578 Thousand | -509 Thousand | -3.19 Million | 3.49 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -8.58 Million | -15.07 Million | 21.41 Million | 801 Thousand | -6.45 Million | -1.85 Million |
| Cash at beginning of period | 759.54 Million | 240.33 Million | 256.84 Million | 382.76 Million | 307.83 Million | 343.35 Million |
| Cash at end of period | 706.95 Million | 759.54 Million | 239.56 Million | 239.56 Million | 256.84 Million | 307.83 Million |
| Capital Expenditure | -841 Thousand | -532.99 Thousand | -1.47 Million | -10.98 Million | -1.49 Million | -4.38 Million |
| Effect of forex changes on cash | 1.41 Million | -1.18 Million | 9.77 Million | 15.03 Million | -9.3 Million | 7.23 Million |
| Net cash flow / Change in cash | -52.58 Million | 519.2 Million | -17.28 Million | -143.19 Million | -50.98 Million | -35.52 Million |
| Free Cash Flow | -51.92 Million | -41.04 Million | -26.3 Million | -156.57 Million | -41.68 Million | -42.53 Million |
WSP
SKHSF
460940
601009
CWIR
5715